Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Surgical Mesh | 7 | 2020 | 57 | 2.470 |
Why?
|
| Herniorrhaphy | 4 | 2020 | 38 | 2.220 |
Why?
|
| Nanoparticles | 10 | 2021 | 254 | 1.890 |
Why?
|
| Drug Delivery Systems | 8 | 2021 | 236 | 1.540 |
Why?
|
| Polypropylenes | 4 | 2020 | 31 | 1.450 |
Why?
|
| Antibodies | 3 | 2015 | 241 | 0.950 |
Why?
|
| Drug Carriers | 2 | 2017 | 90 | 0.940 |
Why?
|
| Muramidase | 4 | 2011 | 38 | 0.740 |
Why?
|
| Liposomes | 3 | 2017 | 107 | 0.730 |
Why?
|
| Coated Materials, Biocompatible | 3 | 2017 | 54 | 0.730 |
Why?
|
| Abdominal Wall | 2 | 2020 | 20 | 0.730 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2020 | 234 | 0.720 |
Why?
|
| Lysostaphin | 4 | 2011 | 4 | 0.700 |
Why?
|
| Varicose Ulcer | 1 | 2020 | 42 | 0.690 |
Why?
|
| Leg | 1 | 2020 | 191 | 0.660 |
Why?
|
| Superoxide Dismutase | 4 | 2013 | 149 | 0.640 |
Why?
|
| Drug Liberation | 1 | 2017 | 17 | 0.610 |
Why?
|
| Laurates | 1 | 2017 | 4 | 0.600 |
Why?
|
| Monoglycerides | 1 | 2017 | 7 | 0.600 |
Why?
|
| Antioxidants | 2 | 2017 | 304 | 0.580 |
Why?
|
| Vitamin E | 1 | 2017 | 55 | 0.580 |
Why?
|
| Enzymes, Immobilized | 3 | 2013 | 11 | 0.490 |
Why?
|
| Neuroprotective Agents | 2 | 2021 | 317 | 0.470 |
Why?
|
| Enzymes | 2 | 2011 | 25 | 0.450 |
Why?
|
| Oxidative Stress | 1 | 2017 | 718 | 0.450 |
Why?
|
| Spinal Cord Injuries | 4 | 2021 | 551 | 0.390 |
Why?
|
| Enbucrilate | 1 | 2011 | 5 | 0.390 |
Why?
|
| Enzyme Therapy | 1 | 2011 | 4 | 0.380 |
Why?
|
| Biomedical Engineering | 1 | 2011 | 20 | 0.380 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 1026 | 0.360 |
Why?
|
| Anti-Infective Agents | 2 | 2011 | 166 | 0.360 |
Why?
|
| Staphylococcal Infections | 4 | 2011 | 156 | 0.350 |
Why?
|
| Estrogens | 2 | 2021 | 173 | 0.350 |
Why?
|
| Staphylococcus aureus | 4 | 2017 | 175 | 0.340 |
Why?
|
| Silicon Dioxide | 2 | 2011 | 61 | 0.330 |
Why?
|
| Thrombolytic Therapy | 1 | 2011 | 233 | 0.330 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 3 | 2018 | 85 | 0.320 |
Why?
|
| Rabbits | 2 | 2020 | 509 | 0.310 |
Why?
|
| Animals | 19 | 2021 | 20880 | 0.300 |
Why?
|
| Estradiol | 2 | 2020 | 176 | 0.290 |
Why?
|
| Polymers | 3 | 2018 | 244 | 0.260 |
Why?
|
| Surgical Wound Infection | 3 | 2011 | 168 | 0.260 |
Why?
|
| Rats | 11 | 2021 | 5300 | 0.260 |
Why?
|
| Pilot Projects | 2 | 2020 | 1341 | 0.240 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2011 | 144 | 0.240 |
Why?
|
| Nanostructures | 1 | 2004 | 112 | 0.220 |
Why?
|
| Lactic Acid | 2 | 2014 | 86 | 0.200 |
Why?
|
| Myelin Sheath | 1 | 2021 | 115 | 0.190 |
Why?
|
| Male | 12 | 2021 | 37283 | 0.180 |
Why?
|
| Nanotubes, Carbon | 2 | 2015 | 73 | 0.180 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 2550 | 0.160 |
Why?
|
| Exercise Therapy | 1 | 2020 | 183 | 0.160 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 2015 | 31 | 0.160 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2011 | 317 | 0.150 |
Why?
|
| Bone Wires | 1 | 2017 | 8 | 0.150 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2017 | 8 | 0.150 |
Why?
|
| Albumins | 1 | 2017 | 72 | 0.150 |
Why?
|
| Solutions | 1 | 2017 | 115 | 0.150 |
Why?
|
| Rectus Abdominis | 1 | 2017 | 9 | 0.150 |
Why?
|
| Wound Healing | 2 | 2017 | 260 | 0.150 |
Why?
|
| Dexamethasone | 1 | 2017 | 150 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2021 | 2083 | 0.140 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 226 | 0.140 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 92 | 0.140 |
Why?
|
| Water | 1 | 2017 | 228 | 0.140 |
Why?
|
| Prostheses and Implants | 1 | 2017 | 159 | 0.140 |
Why?
|
| Motivation | 1 | 2020 | 561 | 0.140 |
Why?
|
| Models, Animal | 1 | 2017 | 252 | 0.130 |
Why?
|
| Kinetics | 1 | 2017 | 1047 | 0.130 |
Why?
|
| Lipids | 1 | 2017 | 298 | 0.130 |
Why?
|
| Surface Plasmon Resonance | 1 | 2015 | 50 | 0.130 |
Why?
|
| Nanocapsules | 1 | 2015 | 10 | 0.130 |
Why?
|
| Complement Inactivator Proteins | 1 | 2014 | 20 | 0.120 |
Why?
|
| Anti-Infective Agents, Local | 2 | 2011 | 40 | 0.120 |
Why?
|
| Carbon | 1 | 2015 | 122 | 0.120 |
Why?
|
| Exercise | 1 | 2020 | 658 | 0.120 |
Why?
|
| Spinal Cord | 1 | 2015 | 244 | 0.120 |
Why?
|
| Surface Properties | 3 | 2018 | 363 | 0.110 |
Why?
|
| Colon | 1 | 2014 | 168 | 0.110 |
Why?
|
| Humans | 10 | 2021 | 68549 | 0.110 |
Why?
|
| Microscopy, Atomic Force | 3 | 2008 | 66 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 219 | 0.110 |
Why?
|
| Complement System Proteins | 1 | 2014 | 135 | 0.110 |
Why?
|
| Colitis | 1 | 2014 | 156 | 0.110 |
Why?
|
| Brain Infarction | 1 | 2013 | 54 | 0.110 |
Why?
|
| Cattle | 2 | 2011 | 475 | 0.110 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 201 | 0.100 |
Why?
|
| Cell Phone | 1 | 2012 | 43 | 0.100 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2013 | 266 | 0.100 |
Why?
|
| Meditation | 1 | 2012 | 33 | 0.100 |
Why?
|
| Prehypertension | 1 | 2012 | 40 | 0.100 |
Why?
|
| Monitoring, Ambulatory | 1 | 2012 | 84 | 0.100 |
Why?
|
| beta-Defensins | 1 | 2011 | 8 | 0.100 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2011 | 21 | 0.100 |
Why?
|
| Hernia, Abdominal | 1 | 2011 | 7 | 0.100 |
Why?
|
| Actins | 2 | 2011 | 249 | 0.100 |
Why?
|
| Stainless Steel | 1 | 2011 | 31 | 0.100 |
Why?
|
| Adsorption | 3 | 2011 | 225 | 0.100 |
Why?
|
| Neurons | 2 | 2021 | 881 | 0.100 |
Why?
|
| Polyglycolic Acid | 1 | 2011 | 20 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2011 | 2673 | 0.100 |
Why?
|
| Protein Binding | 2 | 2011 | 1027 | 0.090 |
Why?
|
| Heart Rate | 1 | 2012 | 568 | 0.090 |
Why?
|
| Particle Size | 2 | 2015 | 201 | 0.090 |
Why?
|
| Reperfusion Injury | 1 | 2013 | 320 | 0.090 |
Why?
|
| Complex Mixtures | 1 | 2009 | 14 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2012 | 402 | 0.090 |
Why?
|
| Molecular Structure | 1 | 2011 | 397 | 0.090 |
Why?
|
| Interleukin-8 | 1 | 2009 | 71 | 0.090 |
Why?
|
| Respiratory Mucosa | 1 | 2009 | 52 | 0.090 |
Why?
|
| Muscle Relaxation | 1 | 2009 | 31 | 0.080 |
Why?
|
| Inflammation | 1 | 2015 | 1030 | 0.080 |
Why?
|
| Microtubules | 1 | 2009 | 104 | 0.080 |
Why?
|
| Peroxidase | 2 | 2007 | 40 | 0.080 |
Why?
|
| Bacteriolysis | 1 | 2008 | 2 | 0.080 |
Why?
|
| Micrococcus | 1 | 2008 | 4 | 0.080 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2008 | 6 | 0.080 |
Why?
|
| Culture Media, Serum-Free | 1 | 2008 | 35 | 0.080 |
Why?
|
| Polystyrenes | 1 | 2008 | 20 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 499 | 0.080 |
Why?
|
| Molecular Weight | 1 | 2008 | 358 | 0.080 |
Why?
|
| Static Electricity | 1 | 2008 | 91 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 1070 | 0.080 |
Why?
|
| Models, Cardiovascular | 1 | 2008 | 133 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 742 | 0.070 |
Why?
|
| Polyethylene Glycols | 1 | 2008 | 149 | 0.070 |
Why?
|
| Cell Adhesion | 3 | 2018 | 324 | 0.070 |
Why?
|
| Fullerenes | 1 | 2007 | 18 | 0.070 |
Why?
|
| Stents | 1 | 2011 | 657 | 0.070 |
Why?
|
| Mice | 5 | 2021 | 8474 | 0.070 |
Why?
|
| Nanotechnology | 1 | 2007 | 109 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2012 | 824 | 0.070 |
Why?
|
| Chymotrypsin | 1 | 2004 | 11 | 0.060 |
Why?
|
| Proteins | 1 | 2008 | 473 | 0.060 |
Why?
|
| Middle Aged | 2 | 2020 | 21119 | 0.060 |
Why?
|
| Neoplasms | 1 | 2015 | 1664 | 0.060 |
Why?
|
| Biomarkers | 3 | 2015 | 1593 | 0.060 |
Why?
|
| Chickens | 1 | 2004 | 232 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 618 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2004 | 791 | 0.050 |
Why?
|
| RAW 264.7 Cells | 1 | 2021 | 42 | 0.050 |
Why?
|
| Rats, Inbred Lew | 2 | 2011 | 150 | 0.050 |
Why?
|
| Tensile Strength | 2 | 2011 | 90 | 0.050 |
Why?
|
| Thoracic Vertebrae | 1 | 2021 | 52 | 0.050 |
Why?
|
| Parenchymal Tissue | 1 | 2020 | 4 | 0.050 |
Why?
|
| Gliosis | 1 | 2020 | 51 | 0.050 |
Why?
|
| Cell Death | 1 | 2021 | 329 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2020 | 42 | 0.050 |
Why?
|
| Microglia | 1 | 2021 | 143 | 0.040 |
Why?
|
| Female | 2 | 2020 | 38021 | 0.040 |
Why?
|
| Elasticity | 2 | 2009 | 103 | 0.040 |
Why?
|
| Stress, Mechanical | 2 | 2009 | 208 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2020 | 506 | 0.040 |
Why?
|
| Soybeans | 2 | 2007 | 11 | 0.030 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 1 | 2015 | 15 | 0.030 |
Why?
|
| Diffusion | 1 | 2015 | 90 | 0.030 |
Why?
|
| Chemokines | 1 | 2015 | 119 | 0.030 |
Why?
|
| Dextran Sulfate | 1 | 2014 | 88 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2014 | 59 | 0.030 |
Why?
|
| Aortic Aneurysm | 1 | 2014 | 77 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2014 | 411 | 0.030 |
Why?
|
| Complement Activation | 1 | 2014 | 145 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2014 | 376 | 0.030 |
Why?
|
| Vascular Calcification | 1 | 2014 | 131 | 0.030 |
Why?
|
| Awareness | 1 | 2012 | 81 | 0.030 |
Why?
|
| Respiration | 1 | 2012 | 91 | 0.030 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2012 | 89 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2014 | 204 | 0.020 |
Why?
|
| Cathelicidins | 1 | 2011 | 11 | 0.020 |
Why?
|
| Cell Shape | 1 | 2011 | 37 | 0.020 |
Why?
|
| Fasciotomy | 1 | 2011 | 12 | 0.020 |
Why?
|
| Dermis | 1 | 2011 | 29 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2011 | 77 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2011 | 236 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 282 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 866 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 337 | 0.020 |
Why?
|
| Reference Values | 1 | 2011 | 579 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 442 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2011 | 301 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 507 | 0.020 |
Why?
|
| Internet | 1 | 2012 | 390 | 0.020 |
Why?
|
| Hippocampus | 1 | 2013 | 471 | 0.020 |
Why?
|
| Cytochalasin D | 1 | 2009 | 10 | 0.020 |
Why?
|
| Nocodazole | 1 | 2009 | 11 | 0.020 |
Why?
|
| Swine | 1 | 2011 | 672 | 0.020 |
Why?
|
| Tubulin Modulators | 1 | 2009 | 10 | 0.020 |
Why?
|
| Immunization | 1 | 2009 | 86 | 0.020 |
Why?
|
| Viscosity | 1 | 2009 | 72 | 0.020 |
Why?
|
| Depsipeptides | 1 | 2009 | 21 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2011 | 247 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 848 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1040 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 1174 | 0.020 |
Why?
|
| Hardness | 1 | 2008 | 20 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2009 | 140 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 929 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 946 | 0.020 |
Why?
|
| Aorta | 1 | 2009 | 316 | 0.020 |
Why?
|
| Linear Models | 1 | 2009 | 521 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 1753 | 0.020 |
Why?
|
| Catalysis | 1 | 2007 | 123 | 0.020 |
Why?
|
| Electrochemistry | 1 | 2007 | 70 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 371 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1174 | 0.020 |
Why?
|
| Graphite | 1 | 2007 | 46 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2012 | 1449 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2007 | 155 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 1641 | 0.020 |
Why?
|
| South Carolina | 1 | 2012 | 2752 | 0.020 |
Why?
|
| Cell Line | 1 | 2009 | 1752 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2011 | 2004 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2004 | 72 | 0.020 |
Why?
|
| Models, Biological | 1 | 2009 | 981 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2004 | 136 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2008 | 706 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 322 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 2077 | 0.010 |
Why?
|
| Binding Sites | 1 | 2004 | 631 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 4655 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2004 | 546 | 0.010 |
Why?
|
| Smoking | 1 | 2009 | 1449 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 5720 | 0.010 |
Why?
|
| United States | 1 | 2013 | 7338 | 0.010 |
Why?
|
| Stroke | 1 | 2013 | 2162 | 0.010 |
Why?
|
| Adult | 1 | 2012 | 21379 | 0.010 |
Why?
|